ArticleJournal of personalized medicine2022

A Novel Integrated Biomarker for Evaluation of Risk and Severity of Coronary Atherosclerosis, and Its Validation.

Victoria A Metelskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.